Functional Role of Histidine in the Conserved His-x-Asp Motif in the Catalytic Core of Protein Kinases

The His-x-Asp (HxD) motif is one of the most conserved structural components of the catalytic core of protein kinases; however, the functional role of the conserved histidine is unclear. Here we report that replacement of the HxD-histidine with Arginine or Phenylalanine in Aurora A abolishes both the catalytic activity and auto-phosphorylation, whereas the Histidine-to-tyrosine impairs the catalytic activity without affecting its auto-phosphorylation. Comparisons of the crystal structures of wild-type (WT) and mutant Aurora A demonstrate that the impairment of the kinase activity is accounted for by (1) disruption of the regulatory spine in the His-to-Arg mutant, and (2) change in the geometry of backbones of the Asp-Phe-Gly (DFG) motif and the DFG-1 residue in the His-to-Tyr mutant. In addition, bioinformatics analyses show that the HxD-histidine is a mutational hotspot in tumor tissues. Moreover, the H174R mutation of the HxD-histidine, in the tumor suppressor LKB1 abrogates the inhibition of anchorage-independent growth of A549 cells by WT LKB1. Based on these data, we propose that the HxD-histidine is involved in a conserved inflexible organization of the catalytic core that is required for the kinase activity. Mutation of the HxD-histidine may also be involved in the pathogenesis of some diseases including cancer.

[1]  P. Marignani,et al.  LKB1 catalytically deficient mutants enhance cyclin D1 expression. , 2007, Cancer Research.

[2]  Susan S. Taylor,et al.  Protein kinases: evolution of dynamic regulatory proteins. , 2011, Trends in biochemical sciences.

[3]  Susan S. Taylor,et al.  Surface comparison of active and inactive protein kinases identifies a conserved activation mechanism , 2006, Proceedings of the National Academy of Sciences.

[4]  T. Hunter,et al.  Evolution of protein kinase signaling from yeast to man. , 2002, Trends in biochemical sciences.

[5]  Susan S. Taylor,et al.  Regulation of protein kinases; controlling activity through activation segment conformation. , 2004, Molecular cell.

[6]  Randy J. Read,et al.  Phenix - a comprehensive python-based system for macromolecular structure solution , 2012 .

[7]  M. Costanza,et al.  Molecular and Clinical Characteristics in 46 Families Affected with Peutz–Jeghers Syndrome , 2007, Digestive Diseases and Sciences.

[8]  P. Emsley,et al.  Features and development of Coot , 2010, Acta crystallographica. Section D, Biological crystallography.

[9]  Z. Otwinowski,et al.  [20] Processing of X-ray diffraction data collected in oscillation mode. , 1997, Methods in enzymology.

[10]  E. Birney,et al.  Patterns of somatic mutation in human cancer genomes , 2007, Nature.

[11]  Nathaniel J. Traaseth,et al.  Allosteric cooperativity in protein kinase A , 2008, Proceedings of the National Academy of Sciences.

[12]  Susan S. Taylor,et al.  Phosphoryl transfer by protein kinase A is captured in a crystal lattice. , 2013, Journal of the American Chemical Society.

[13]  G. Murshudov,et al.  Refinement of macromolecular structures by the maximum-likelihood method. , 1997, Acta crystallographica. Section D, Biological crystallography.

[14]  R. Bayliss,et al.  A Kinetic Test Characterizes Kinase Intramolecular and Intermolecular Autophosphorylation Mechanisms , 2013, Science Signaling.

[15]  Lynn F. Ten Eyck,et al.  A helix scaffold for the assembly of active protein kinases , 2008, Proceedings of the National Academy of Sciences.

[16]  J. Adams,et al.  Kinetic and catalytic mechanisms of protein kinases. , 2001, Chemical reviews.

[17]  D. Kern,et al.  Molecular mechanism of Aurora A kinase autophosphorylation and its allosteric activation by TPX2 , 2014, eLife.

[18]  M. Lemmon,et al.  EGF-independent activation of cell-surface EGF receptors harboring mutations found in gefitinib-sensitive lung cancer , 2007, Oncogene.

[19]  R. Knegtel,et al.  Crystal Structure of Aurora-2, an Oncogenic Serine/Threonine Kinase* , 2002, The Journal of Biological Chemistry.

[20]  M. Mohammadi,et al.  A molecular brake in the kinase hinge region regulates the activity of receptor tyrosine kinases. , 2007, Molecular cell.

[21]  L. Johnson,et al.  Active and Inactive Protein Kinases: Structural Basis for Regulation , 1996, Cell.

[22]  J. Adams.  Activation loop phosphorylation and catalysis in protein kinases: is there functional evidence for the autoinhibitor model? , 2003, Biochemistry.

[23]  D. Neil Hayes,et al.  LKB1 modulates lung cancer differentiation and metastasis , 2007, Nature.

[24]  James E. Ferrell,et al.  Mechanisms of specificity in protein phosphorylation , 2007, Nature Reviews Molecular Cell Biology.

[25]  Liu Wei,et al.  LKB1 inactivation dictates therapeutic response of non-small cell lung cancer to the metabolism drug phenformin. , 2013, Cancer cell.

[26]  Maria Deak,et al.  Structure of the LKB1-STRAD-MO25 Complex Reveals an Allosteric Mechanism of Kinase Activation , 2009, Science.

[27]  N. Schork,et al.  Prediction of cancer driver mutations in protein kinases. , 2008, Cancer research.

[28]  P. Guglielmelli,et al.  Clinical implications of the JAK2 V617F mutation in essential thrombocythemia , 2005, Leukemia.

[29]  Jing Wu,et al.  LKB1 inhibits lung cancer progression through lysyl oxidase and extracellular matrix remodeling , 2010, Proceedings of the National Academy of Sciences.

[30]  John Kuriyan,et al.  A Src-Like Inactive Conformation in the Abl Tyrosine Kinase Domain , 2006, PLoS biology.

[31]  J. Kuriyan,et al.  The Conformational Plasticity of Protein Kinases , 2002, Cell.

[32]  Brian H. Dunford-Shore,et al.  Somatic mutations affect key pathways in lung adenocarcinoma , 2008, Nature.

[33]  N. Kannan,et al.  Identification of a hidden strain switch provides clues to an ancient structural mechanism in protein kinases , 2012, Proceedings of the National Academy of Sciences.

[34]  David Sidransky,et al.  Inactivation of LKB1/STK11 is a common event in adenocarcinomas of the lung. , 2002, Cancer research.

[35]  Susan S. Taylor,et al.  Defining the Conserved Internal Architecture of a Protein Kinase , 2010, Biochimica et biophysica acta.

[36]  T. Hunter,et al.  The eukaryotic protein kinase superfamily: kinase (catalytic) domain structure and classification 1 , 1995, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[37]  P. Laurent-Puig,et al.  Genome wide SNP comparative analysis between EGFR and KRAS mutated NSCLC and characterization of two models of oncogenic cooperation in non-small cell lung carcinoma , 2008, BMC Medical Genomics.

[38]  Vincent B. Chen,et al.  Correspondence e-mail: , 2000 .

[39]  A. F. Neuwald,et al.  Did protein kinase regulatory mechanisms evolve through elaboration of a simple structural component? , 2005, Journal of molecular biology.

[40]  N Srinivasan,et al.  Structural modes of stabilization of permissive phosphorylation sites in protein kinases: distinct strategies in Ser/Thr and Tyr kinases. , 2004, Journal of molecular biology.

[41]  Susan S. Taylor,et al.  Deciphering the Structural Basis of Eukaryotic Protein Kinase Regulation , 2013, PLoS biology.

[42]  T. Hunter,et al.  The Protein Kinase Complement of the Human Genome , 2002, Science.

[43]  Tao Yu,et al.  Dynamics connect substrate recognition to catalysis in protein kinase A. , 2010, Nature chemical biology.

[44]  H. Clevers,et al.  Dysfunctional AMPK activity, signalling through mTOR and survival in response to energetic stress in LKB1-deficient lung cancer , 2007, Oncogene.